Schedule 13G ownership disclosure
MEREO BIOPHARMA GROUP PLC
American Depositary Shares · CUSIP: 589492107
Event date: 2024-11-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 15,917,259 · Class: 10.3%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 14,384,501 · Class: 9.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000278
- Form type
- SCHEDULE 13G/A
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Dec 06, 2024
- Reporting period
- Nov 29, 2024
- Description
- Schedule 13G beneficial ownership